Deep Sternal Wound Infection (DSWI) and Mediastinitis After Cardiac Surgery: Current Approaches and Future Trends in Prevention and Management.


Journal

Surgical technology international
ISSN: 1090-3941
Titre abrégé: Surg Technol Int
Pays: United States
ID NLM: 9604509

Informations de publication

Date de publication:
28 May 2020
Historique:
pubmed: 28 3 2020
medline: 3 6 2020
entrez: 28 3 2020
Statut: ppublish

Résumé

Median sternotomy is the most common access for cardiac surgery. Deep surgical wound infection (DSWI) and mediastinitis after median sternotomy remain significant clinical problems after cardiac surgery in terms of mortality, morbidity and healthcare-associated costs. Despite recent advances in medical management and consensus papers, their incidence ranges from 1% to 5%, and the associated mortality ranges from 20% to 50%. Recent studies in this field are providing excellent outcomes with promising results for the near future. The choice of sternal closure technique plays a crucial role in the prevention of DSWI and mediastinitis and should be tailored to the patient's characteristics, as clinical judgement and experience play a pivotal role. Early aggressive surgical debridement, vacuum-assisted closure (VAC) therapy, muscle flap and newer technologies are revolutionizing the paradigm of treatment of DSWI. Also, recent advances in tissue engineering have been refining potential approaches to tissue regeneration or substitution for enhanced wound repair. This editorial aims to briefly summarize the current and future techniques in DSWI prevention and treatment after cardiac surgery.

Identifiants

pubmed: 32215903
pii: sti36/1240

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-216

Auteurs

Camilla Chello (C)

Università La Sapienza di Roma, Rome, Italy.

Mario Lusini (M)

Università Campus Bio-Medico di Roma, Rome, Italy.

Antonio Nenna (A)

Università Campus Bio-Medico di Roma, Rome, Italy.

Francesco Nappi (F)

Centre Cardiologique du Nord, Saint Denis, Paris, France.

Cristiano Spadaccio (C)

Golden Jubilee National Hospital, Glasgow, UK.

Umberto Maria Satriano (UM)

Università Campus Bio-Medico di Roma, Rome, Italy.

Francesco Cardetta (F)

Università Campus Bio-Medico di Roma, Rome, Italy.

Ciro Mastroianni (C)

Università Campus Bio-Medico di Roma, Rome, Italy.

Massimo Chello (M)

Università Campus Bio-Medico di Roma, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH